Investment Summary

The Carlyle Group Invests In Piramal Pharma Solutions

On June 27, 2020, private equity firm The Carlyle Group invested in life science company Piramal Pharma Solutions

Investment Highlights
  • This is The Carlyle Group’s 16th transaction in the Life Science sector.
  • This is The Carlyle Group’s 322nd transaction in the United States.
  • This is The Carlyle Group’s 3rd transaction in Kentucky.

Investment Summary
Date 2020-06-27
Target Piramal Pharma Solutions
Sector Life Science
Investor(s) The Carlyle Group
Deal Type Stake Purchase

Target

Piramal Pharma Solutions

Lexington, Kentucky, United States
Piramal Pharma Solutions is a Contract Development and Manufacturing Organization (CDMO), part of Piramal Enterprises Ltd. The company instills patient-centric ethos in our work that transcends cultural boundaries with the fundamental objective of reducing the burden of disease. At every level of our organization, we keep patients first. It offers Pharmaceutical Discovery, Development, and Manufacturing solutions through collaborative partnership models by working with customers throughout the drug life cycle. Piramal Pharma Solutions was formed in 1988 and is based in Lexington, Kentucky.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

The Carlyle Group

Washington, District of Columbia, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1987
PE ASSETS 435.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.

The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.

DEAL STATS #
Overall 670 of 744
Sector (Life Science) 16 of 19
Type (Stake Purchase) 66 of 73
State (Kentucky) 3 of 3
Country (United States) 322 of 349
Year (2020) 8 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-25 Eggplant

London, United Kingdom

Eggplant enables organizations to test, monitor, analyze, and report on the quality and responsiveness of software applications across different interfaces, platforms, browsers, and devices, including mobile, IoT, desktop, and mainframe. Eggplant is based in London, United Kingdom.

Sell $330M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-29 ENVEA

Poissy, France

ENVEA is manufacturing ambient, emissions, and process monitoring systems, with full turnkey capabilities (gas analyzers, dust monitors, solids and flue gas flow meters, air quality surveillance networks) completed by environmental data processing & reporting solutions. ENVEA was formed in 1978 and is based in Poissy, France.

Buy -
Mergr

Product

Company

Legal